Article

Manipulation of Schlemm's effective in treating glaucoma

According to Manfred Tetz and colleagues, Germany, dilation and tensioning of Schlemm's canal may be an effective, non-penetrating surgical method for the treatment of open angle glaucoma (OAG).

According to Manfred Tetz and colleagues, Germany, dilation and tensioning of Schlemm's canal may be an effective, non-penetrating surgical method for the treatment of open angle glaucoma (OAG).

The authors conducted a multicentre, prospective clinical study at three German outpatient surgical centres to determine the safety and efficacy of dilation and tensioning of Schlemm's canal during non-penetrating surgery in glaucoma patients.

A flexible microcannula was introduced into the canal, following surgical exposure, to perform viscodilation of the canal and associated collector channels. The microcannula was used, after 360 degrees of canal cannulation, to insert a 10-0 prolene suture to tension the inner wall of the canal and related trabecular meshwork. Postoperatively, subjects were examined to evaluate the anterior segment and intraocular pressure (IOP), a number of patients were also examined using high resolution ultrasound imaging of the anterior segment angle to evaluate the Schlemm's canal morphology.

To date, the results from 71 subjects have been gathered. Tensioning sutures were observed to distend the inner wall of the canal and trabecular meshwork, whilst also maintaining the canal lumen. Average IOP at six months follow up (n=26) was 14.4 mmHg with an average of 0.2 medications being used. Just four subjects reported adverse events.

Tetz and co-workers noted that viscodilation of the canal restored physiologic drainage and controlled IOP levels. Consequently, they concluded that dilation and tensioning could be an effective non-penetrating surgical method for the treatment of OAG.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.